Navigation Links
Impressive new Impact Factors for BioMed Central's open-access journals

Eleven journals published by BioMed Central, the open access publisher, received their first Impact Factor this month. With nine journals in the top 10 of their 2005 Journal Citation Report* category, and ten journals with a 2005 Impact Factor exceeding 3.00, open access journals are confirmed as publishing high-quality, highly cited research.

Genome Biology, BioMed Central's flagship title covering biology in the post-genomic era, has been assessed as having an Impact Factor of 9.71. The journal's first Impact Factor places it in the top five of research journals in the highly competitive Genetics and Heredity field, and the 4th most cited journal in the Biotechnology & Applied Microbiology. Matthew Cockerill, BioMed Central's Publisher, comments, "Genome Biology's impressive Impact Factor is evidence of BioMed Central's commitment to quality, and shows that top researchers at the cutting edge of biology are increasingly choosing open access publication for their best work."

Malaria Journal, with a first Impact Factor of 2.14, is the number two journal in the Tropical Medicine field, and number five in the Parasitology category. Launched in 2001, Malaria Journal was one of the first journals started as part of BioMed Central's independent journal program, and is the first of these independent journals to receive an Impact Factor.

Seven journals in the BMC series also received their first Impact Factors this year. BMC Developmental Biology, with an Impact Factor of 5.41, is ranked at number six in the developmental biology field. BMC Structural Biology enters the Biophysics category at number eight, with an Impact Factor of 5.00. BMC Evolutionary Biology's Impact Factor of 4.45 is the 6th most highly cited journal in the evolutionary biology category. BMC Biotechnology now has an Impact Factor of 3.05, BMC Neuroscience 2.73, BMC Microbiology 2.18, BMC Gastroenterology 1.46.

Dr Cockerill continues, "These impressive rankings demonst
'"/>

Source:BioMed Central


Page: 1 2

Related biology news :

1. Study Models Impact Of Anthrax Vaccine
2. BioMed Central welcomes the new National Institutes of Health public access policy
3. BioMed Central launches Biology Direct
Post Your Comments:
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides ... and fingerprinting markets. Watermarking aims to control and ...
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced the ... Security Systems Market" report to their offering. ... perimeter security market is estimated to grow at a CAGR ... holds a larger share in this market, Canada ...
(Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research and Markets ... of the "Samsung Galaxy S5 - Home Button ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... the iPhone 5S, Samsung introduces for the first time ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... AUSTIN, TexasGroove-like tracks on the ocean floor made by ... into the evolutionary origin of animals, says biologist Mikhail ... Matz and his colleagues recently discovered the ... floor near the Bahamas. This is the first time ...
... 2008 -- A team led by Thomas Schulthess of ... received the prestigious 2008 Association for Computing Machinery (ACM) ... ever in a scientific supercomputing application. Schulthess is ... recently accepted a position as director of the Swiss ...
... strangers. When its security patrol spots a foreign cell, ... people with type 1 diabetes undergo human islet cell ... robust amounts of insulin for the recipient -- often ... tries to kill the new hard-working islets. A ...
Cached Biology News:Discovery of giant roaming deep sea protist provides new perspective on animal evolution 2Discovery of giant roaming deep sea protist provides new perspective on animal evolution 3ORNL supercomputer simulation wins prize for fastest-running science application 2ORNL supercomputer simulation wins prize for fastest-running science application 3New technique eliminates toxic drugs in islet transplant in diabetic mice 2
(Date:1/22/2015)... 22, 2015   Cypher Genomics, Inc., the ... SQNM ), the leading molecular diagnostics ... generation noninvasive prenatal tests (NIPT). Through this agreement, ... Mantis™, to advance analysis of clinically-relevant fetal sub-chromosomal ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... 2014 GMO corn cases filed across the ... the process of being consolidated in a Kansas federal court ... AG MIR 162 Corn Litigation, MDL No. 2591 in the ... of the Syngenta GMO corn multidistrict litigation (MDL) has been ...
(Date:12/24/2014)... December 23, 2014 The report ... its definition, classification, application and industry overview. This ... product cost structure. Production is separated by regions, ... raw materials, equipment, downstream client survey, marketing channels, ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... Amsterdam,Molecular Therapeutics (Euronext: AMT), a leader in the ... of Mrs. Janneke de Wal, M.D., as,Director Global ... J.,Gringeri, Ph.D., Chief Operating Officer. She will also ... Wal has over 20 years of experience in ...
... of two kinds of bacteria to produce hydrogen in a ... other. According to an article in the August issue of ... leftover enzymes can be used to scavenge precious metals from ... hydrogen into energy. , Hydrogen has three times more potential ...
... Aug. 6, 2008 TIME: ... Dr. Candace Kendle, Chairman and CEO, Kendle (Nasdaq: ... Wednesday, Aug. 6 at 9:30 a.m. Eastern Time to,discuss its financial ... answer session will follow., Webcast Instructions, To access the ...
Cached Biology Technology:AMT Appoints Director Global Marketing and Sales 2AMT Appoints Director Global Marketing and Sales 3Fuel from food waste: bacteria provide power 2Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast 2